Biomarkers like elevated fasting insulin or HOMA-IR (insulin resistance index) suggest strong GLP-1 response potential, while baseline GI sensitivities or gastroparesis history may influence dose escalation strategy
Taube and Schwartzkroin (1987) report that, out of 12 basket cells tested, three expressed potentiation, three expressed depression, and in the remaining six cells, no change or a small increase of EPSP amplitude was observed
Most common peptides studied are thymosin alpha-1, BPC-157 and some anti-inflammatory cytokine-derived peptides
Most weight loss occurred within the first 24 weeks, suggesting patients dont need to wait a year to see clear results
Furthermore, SalB attenuated alveolar wall congestion, inflammatory cell infiltration, and emphysema in PF rat lung tissues while exerting notable anti-fibrotic effects
While frustrating, dont stress too much